Related Experiment Video

Updated: May 24, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

Using NF-κB as a molecular target for theranostics in radiation oncology research

Yu-Chang Liu1, I-Tsang Chiang, Fei-Ting Hsu

  • 1Department of Biomedical Imaging & Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.

Expert Review of Molecular Diagnostics
|February 29, 2012
PubMed

Insights

Targeting the NF-κB pathway could overcome cancer cell resistance to chemotherapy and radiotherapy. Inhibiting this pathway may improve treatment outcomes for various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer therapy resistance is a significant clinical challenge.
  • The Nuclear Factor kappa B (NF-κB) signaling pathway is implicated in tumor development, progression, and treatment resistance.
  • Understanding NF-κB's role is crucial for improving cancer treatment efficacy.

Purpose of the Study:

  • To review the role of NF-κB molecules in carcinogenesis and tumor progression.
  • To discuss the clinical significance of the NF-κB pathway in cancer.
  • To explore the potential of NF-κB as a diagnostic and therapeutic target.

Main Methods:

  • Literature review of NF-κB signaling in cancer.
  • Analysis of NF-κB's correlation with tumor development and progression.
  • Discussion of clinical implications and therapeutic strategies.

Main Results:

  • NF-κB signaling is a key factor in cancer development and progression.
  • Inhibition of NF-κB may sensitize resistant cancer cells to chemotherapy and radiotherapy.
  • NF-κB pathway molecules show potential as biomarkers and therapeutic targets.

Conclusions:

  • Targeting the NF-κB pathway offers a promising strategy to overcome cancer treatment resistance.
  • NF-κB and associated molecules represent significant targets for novel cancer diagnostics and therapeutics.

More Related Videos

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...